Vanberra Signal

TexRAD

Curated by Signal

Medical image analysis software for cancer risk assessment, prognosis & diagnosis

Overview

Texrad (now part of Feedback group) is a developer of medical imaging software for diagnosis of cancer. The software named as TexRAD, detects and measures tumor complexity in medical images (CT and MRI) and reveals more information which cannot be available in naked eye observations. The software uses quantitative textural analysis which helps to measure tumor size, density, and perfusion. TexRAD has been validated retrospectively using image analysis of colorectal, breast, lung, prostate, oesophageal, head and neck, and renal cancers patients.

Key facts

Founded
2011

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of medical catheter and tubing protection device

    Life Sciences TechnologyLondon, United Kingdom
  • Provider of orthopedic products for rehabilitation

    Life Sciences TechnologyBasingstoke, United Kingdom

About TexRAD

What does TexRAD do?

Texrad (now part of Feedback group) is a developer of medical imaging software for diagnosis of cancer.

Where is TexRAD headquartered?

TexRAD is headquartered in Cambridge, United Kingdom.

When was TexRAD founded?

TexRAD was founded in 2011.

Which sector is TexRAD in?

TexRAD operates in Life Sciences Technology.

Who are TexRAD's competitors?

Companies similar to TexRAD include Braidlock, Blatchford, and Cambridge Respiratory Innovations.